Skip to content
Open access · CC-BY via OpenAlex

Supramolecular delivery of senolytics enables targeted anti-senescence therapy and accelerated fracture healing

Yonggang Fan, Ze-Han Wang, Xu Zhang, Yu Dong, Xin Liu, Gan Luo, Houzhi Yang, Huinan Li, Zicheng Wang, Qiong Tang, Xin Jin, Dong‐Sheng Guo, Tianwei Sun

Journal of Nanobiotechnology · 2026 · ▲ 3 citations

Abstract

Current clinical management of fractures relies largely on surgical intervention and systemic pharmacotherapy, both of which are frequently associated with side effects and largely neglect early microenvironmental abnormalities. Precise elimination of senescent cells at the early stage may offer a more efficient means of restoring microenvironmental homeostasis and resetting regenerative dynamics. To this end, we designed and synthesized a multifunctional supramolecular nanoplatform, Asp 10 SAC4A, based on combination of host–guest recognition and self-assembly to simultaneously address three fundamental challenges in selectively eliminating senescent cells at the fracture site: inadequate targeting, insufficient responsiveness, and poor coordination of multi-drug delivery. The platform consists of an azocalix [ 4 ]arene modified with a deca-aspartate (Asp 10 ) peptide for selective binding to newly exposed hydroxyapatite at fracture sites, enabling active localization. Simultaneously, Dasatinib and Quercetin are co-loaded in a controlled ratio, and triggered for rapid release through the hypoxia-responsive mechanism of the azo groups, achieving microenvironment-specific “source-clearing” therapy. This strategy significantly alleviates inflammation, enhances osteogenesis and accelerates fracture healing. These results highlight the crucial role of selectively targeting senescent cells in the early phase of fracture and offer an innovative therapeutic approach that improves treatment efficiency and prognosis. Overall, this study aims to establish a fracture-site–activated senolytic delivery strategy that integrates fracture targeting, hypoxia-triggered release, and combination therapy, thereby enabling precise early-stage anti-senescence(definition) intervention to accelerate fracture healing.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1186/s12951-026-04138-2
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Fan, Y., Wang, Z., Zhang, X., Dong, Y., Liu, X., Luo, G., Yang, H., Li, H., Wang, Z., Tang, Q., Jin, X., Guo, D., &amp; Sun, T. (2026). Supramolecular delivery of senolytics enables targeted anti-senescence therapy and accelerated fracture healing. <em>Journal of Nanobiotechnology</em>. https://doi.org/10.1186/s12951-026-04138-2
Vancouver
Fan Y, Wang Z, Zhang X, Dong Y, Liu X, Luo G, et al. Supramolecular delivery of senolytics enables targeted anti-senescence therapy and accelerated fracture healing. Journal of Nanobiotechnology. 2026. doi:10.1186/s12951-026-04138-2.
BibTeX
@article{yonggang2026Supram, title = {Supramolecular delivery of senolytics enables targeted anti-senescence therapy and accelerated fracture healing}, author = {Yonggang Fan and Ze-Han Wang and Xu Zhang and Yu Dong and Xin Liu and Gan Luo and Houzhi Yang and Huinan Li and Zicheng Wang and Qiong Tang and Xin Jin and Dong‐Sheng Guo and Tianwei Sun}, journal = {Journal of Nanobiotechnology}, year = {2026}, doi = {10.1186/s12951-026-04138-2}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings